Complex I deficiency is a common cause of mitochondrial disease, resulting from mutations in genes encoding structural subunits, assembly factors or defects in mitochondrial gene expression. Advances in genetic diagnostics and sequencing have led to identification of several variants in NUBPL, an assembly factor of complex I, which are potentially pathogenic. To help assign pathogenicity and learn more about the function of NUBPL, amino acid substitutions were recreated in the homologous Ind1 protein of the yeast model Yarrowia lipolytica. L102P destabilized the Ind1 protein, leading to a null-mutant phenotype. D103Y, L191F and G285C affected complex I assembly to varying degrees, whereas the G138D variant did not impact on complex I levels or dNADH:ubiquinone activity. Blue-native PAGE and immunolabelling of the structural subunits NUBM and NUCM revealed that all Ind1 variants accumulated a Q-module intermediate of complex I. In the D103Y variant the matrix arm intermediate was virtually absent, indicating a dominant effect. Dysfunction of Ind1, but not absence of complex I, rendered Y. lipolytica sensitive to cold. The Ind1 G285C variant was able to support complex I assembly at 28°C, but not at 10°C. Our results indicate that Ind1 is required for progression of assembly from the Q module to the full matrix arm. Cold sensitivity could be developed as a phenotype assay to demonstrate pathogenicity of NUBPL mutations and other complex I defects.
Introduction
Defects in respiratory chain function underlie a large share of mitochondrial disorders, of which a third are due to complex I deficiency (OMIM 252010) (1) (2) (3) . Clinical presentation such as Leigh syndrome usually occur in infancy or early adulthood. Symptoms include skeletal muscle myopathy, cardiomyopathy, hypotonia, stroke, ataxia and lactic acidosis (3, 4) . Human complex I has 44 different structural subunits, of which 37 are encoded in the nuclear genome and 7 in the mitochondrial genome (5) . Disease-causing mutations have been identified in 26 out of 44 structural genes. However, this only provides a diagnosis for about 50% of cases, as complex I deficiency may also be caused by mutations in assembly factors or mitochondrial gene expression (2, 6) . Assembly factors are defined as proteins which are required for the correct assembly and function of complex I but are not present in the mature structure. So far, 16 assembly proteins have been identified for complex I, and disease-causing mutations have been found in 10 of those (3, 7) . Particularly, advances in genome sequencing have led to the identification of several novel genes affecting complex I function, providing a genetic diagnosis for patients with these rare inheritable conditions. The complex I assembly factor NUBPL (NUcleotide Binding Protein-Like) was first identified in the aerobic yeast Yarrowia lipolytica where it was named Ind1 (Iron-sulfur protein required for NADH dehydrogenase) (8) . Genomic deletion of IND1 resulted in a major decrease in complex I, to approximately 28% of wild-type levels, but it has no effect on other respiratory complexes. Ind1 has been proposed to insert iron-sulfur (FeS) clusters in complex I based on its homology to the cytosolic FeS cluster assembly factors Nbp35 and Cfd1, corresponding to NUBP1 and NUBP2, respectively, in human (9) . However, it should be noted that Ind1 is not essentially required for complex I in Y. lipolytica and it would therefore only have an auxiliary role in cofactor assembly.
Phylogenetic analysis showed that the IND1 gene is present in almost all eukaryotes, and closely matches the distribution of complex I (8) . A study of the human homologue showed that siRNA knockdown of NUBPL in HeLa cells led to a specific decrease in complex I, as well as accumulation of assembly intermediates (10) . Moreover, mutations in NUBPL were identified in patients with complex I deficiency by exome sequencing (1, 11, 12) . Recently, NUBPL was found among 191 genes that are essential for oxidative phosphorylation in a genome-wide screen of CRISPR mutants (13) . The IND1 homologue in the model plant Arabidopsis thaliana is also required for complex I assembly (14) . Combined, these studies show that NUBPL has an evolutionary conserved function in complex I assembly, but its precise molecular function remains to be demonstrated.
So far, 12 different cases of mutations in NUBPL have been reported or newly diagnosed (Table 1) . Patients display various symptoms within the broad spectrum of mitochondrial disorders, including motor problems, increased lactate levels and some degree of complex I deficiency. In addition, NUBPL patients show a very distinct magnetic resonance imaging (MRI) pattern with abnormalities of the cerebellar cortex, deep cerebral white matter and corpus callosum (11) . Genetic diagnoses by exome sequencing revealed that all patients have inherited a branch-site mutation in NUBPL, c.815-27T>C, from either the mother or father.
Except for one suspected homozygous case ( Table 1, patient 3) , all other cases are compound heterozygous carrying a likely deleterious mutation in the other copy of the NUBPL gene ( Table 1 ). The c.815-27T>C mutation affects a splice recognition site in intron 9, leading to aberrant mRNA splicing (15) . Approximately 30% of wild-type NUBPL transcript remains but two miss-spliced transcripts are also produced. One of these disappears by nonsense mediated decay. The other miss-spliced transcript lacks exon 10, leading to D273Q, a frameshift and then a premature stop codon. The predicted protein product, p.D273QfsX31, is unstable, as NUBPL protein is almost undetectable in patient fibroblasts (15) . c.815-27T>C is often co-inherited with a missense c.G166>A mutation (p.G56R), which, on its own, is not thought to be pathogenic (15) , and absent in at least two cases ( Table 1 , patient 2 and siblings 9 and 10).
The haploid yeast Y. lipolytica has been used extensively in biotechnology but it has also been developed as a model organism to study complex I biology (16) (17) (18) (19) (20) . This has been necessary because the usual yeast model Baker's yeast, Saccharomyces cerevisae, does not have complex I. The D273QfsX31 variation of NUBPL was recreated in the Ind1 protein of Y. lipolytica, which confirmed that the altered protein was unable to support the assembly of complex I (21) . Here, we compare six mutations in the NUBPL gene, 3 of which are newly identified, in an effort to assign pathogenicity and to enhance our understanding of the molecular function of NUBPL/Ind1. The resulting protein variants were tested in Y. lipolytica for protein stability and complex I levels, oxidoreductase activity and assembly intermediates.
Together, the results indicate pathogenicity of four missense mutations and reveal that ind1 mutants are sensitive to low temperature.
Results

Selection of NUBPL mutations for analysis in Y. lipolytica
Twelve cases of mitochondrial disorders associated with mutations in NUBPL have been published or were otherwise known to us (Table 1 ). In addition, many more polymorphisms in NUBPL have been uncovered by large-scale exome sequencing (exac.broadinstitute.org), of which V182A and G138D occur at a high allele frequency ( Table 2 ). Mutations that result in early frameshifts, insertions or deletions (patients 1, 2, 4 and 7) are almost certainly deleterious but are unlikely to shed light on the molecular function of NUBPL. Mutations resulting in a single amino acid change at a conserved position, such as L104P (patients 9,10 and 12), D105Y (patients 5,6), G138D (ExAC database), L193F (patient 8) and G287C (patient 11) were chosen for functional analysis in Y. lipolytica. V182 is only semi-conserved in Y. lipolytica Ind1, corresponding to M180, and was therefore not included in this study.
L104P and D105Y affect residues in the highly conserved Switch I motif ( Figure 1A ) involved in ATP hydrolysis; L193F affects a residue just outside the Mrp family signature; and G287C introduces an additional cysteine to the C-terminus. The corresponding amino acids in the Ind1 protein of Y. lipolytica were identified by alignment using Clustal Omega (Figure 1A , B) and this amino acid numbering is used throughout the study. A homology model of Ind1 was made and the positions of the substituted amino acids are indicated in Figure 1C .
Protein stability in Ind1 variants
In order to study the biochemical and physiological effects of the amino acid changes, sitedirected mutations were introduced into a plasmid carrying the IND1 gene under the control of its native promoter and transformed into Y. lipolytica ind1∆ cells, a GB10 strain with a genomic deletion of the IND1 gene (8) . The plasmid contains a chromosomal ARS/CEN region which is maintained at ~1 copy per cell. The GB10 strain was engineered to contain the NDH2i gene, encoding an alternative NADH dehydrogenase targeted to the matrix side of the inner mitochondrial membrane, which bypasses the essential requirement of respiratory complex I in Y. lipolytica (22) . The previously reported variant Ind1 protein N271QfsX31, recapitulating the effect of the c.815-27T>C branch-site mutation in NUBPL, was included for comparison (21) .
Mitochondrial membranes of each strain were isolated and subjected to Western blot analysis to visualize Ind1 protein levels. The D103Y, G136D, L191F and G285C variants displayed levels of Ind1 protein similar to ind1∆ + IND1 (henceforth referred to as complemented wild type, cWT) ( Figure 2A ). The L102P substitution resulted in lower levels of Ind1 protein, to approximately 45% of cWT levels. The decrease in L102P protein was similar to that seen in N271QfsX31. Antibodies against aconitase (Aco1) and subunit 2 of complex II (Sdh2) were used as a loading control and to confirm that other FeS-cluster binding proteins are not affected ( Figure 2A ).
To rule out that lower amounts of the Ind1 L102P protein were due to decreased transcript levels, expression of IND1 was assessed by RT-PCR ( Figure 2B ). Normal levels of IND1 transcript in the L102P variant indicated that the protein undergoes post-translational degradation. In order to further investigate the effect of L102P on protein stability, Ind1 and Ind1 L102P were expressed in E. coli. Separation of soluble and insoluble fractions showed that all Ind1 L102P protein is found in the insoluble pellet fraction, whilst most of the normal Ind1 protein can be found in the soluble fraction. This suggests that the L102P substitution causes protein misfolding, which would result in its degradation by proteases. Overall these data show that, with the exception of L102P, the selected amino acid substitutions in Ind1 do not affect protein stability.
Ind1 variants L102P, D103Y and L191F have strongly decreased levels of complex I
It has previously been shown that cells lacking IND1 have approximately 28% of fully active complex I compared to wild type (8) . To investigate the effect of the amino acid variants in Ind1 on complex I, mitochondrial membranes were separated by blue-native PAGE (BN-PAGE) to resolve the respiratory complexes. Incubation of the gel with NADH and nitro-blue tetrazolium (NBT) reveals NADH dehydrogenase activities, which is used as a proxy to estimate complex I levels (23) . In cells expressing the Ind1 variants L102P and D103Y, complex I was strongly decreased, similar to the levels in the ind1∆ mutant (empty vector control, e.v.) and N271QfsX31 ( Figure 3A To measure oxidoreductase activity of the matrix arm of complex I, two different spectrophotometric assays were used. Electron transfer from NADH to the artificial electron acceptor hexaammineruthenium(III) chloride (HAR) involves only the primary electron acceptor FMN bound to the NUBM subunit of complex I and, like NADH:NBT staining, serves as a proxy for complex I content. The L102P, D103Y, L191F, and N271QfsX31 variants showed a significant decrease in NADH:HAR activity, whereas G136D and G285C were similar to cWT ( Figure 3B , Table S1 ).
To assess NADH:ubiquinone oxidoreductase activity, electron transfer from deamino-NADH (dNADH) to n-decylubiquinone (DBQ) was measured, encompassing all cofactors in the matrix arm of complex I. A significant decrease in electron transfer was seen with the L102P, D103Y, L191F, and N271QfsX31 variants, but not in G136D and G285C ( Figure 3C , Table   S1 ). The nucm∆ + NUCM Y144F mutant had low dNADH:DBQ activity (Table S1 ), despite wildtype levels of fully assembled complex I ( Figure 3A ). Comparison of dNADH:DBQ activity between the Ind1 variants and nucm∆ + NUCM Y144F shows that in the Ind1 variants there is still substantial activity remaining. For the Ind1 variants, the NADH:HAR activities correspond with those of dNADH:DBQ, suggesting that all the complex I present is enzymatically active.
Taken together, the data from three different methods are in agreement and indicate that the L102P and D103Y substitutions in Ind1 cause a defect in complex I assembly of similar severity as IND1 deletion. The L191F substitution caused a mild decrease, whereas G138D and G285C appeared to have no significant effect on complex I levels under standard growth conditions.
All ind1 mutants accumulate a Q module assembly intermediate
In human cell lines depleted of NUBPL, a subcomplex representing part of the membrane arm was observed (10) . Similarly, the Arabidopsis indh mutant had a membrane arm assembly intermediate, but no full-size complex I (14) . To investigate complex I assembly in Y. lipolytica cells lacking Ind1, the ind1∆ strain was compared to mutant strains of different subunits of the matrix arm of complex I, nubm∆, nucm∆ and nukm∆. NUBM is the homologue of the human NDUFV1 protein (bovine 51-kDa subunit) in the N-module. NUCM (human NDUFS2, bovine 49 kDa) and NUKM (human NDUFS7, bovine PSST) are in the Q-module ( Figure 4A ). In the ind1∆ mutant, the protein levels of NUBM are slightly decreased but the levels of NUCM are not affected ( Figure 4B ). Thus, compared to the decreased levels of complex I in ind1∆, NUBM and NUCM are imported into the mitochondrial matrix but the majority is not assembled.
Decreased levels of NUBM are also seen in the nucm∆ and nukm∆ mutants, indicating that if the Q-module is not assembled, NUBM is degraded.
Mitochondrial membranes were isolated from cWT, ind1∆, nubm∆, nucm∆ and nukm∆ and the respiratory complexes were separated by BN-PAGE, followed by Western blotting with antibodies against NUBM and NUCM. This confirmed the lack of complex I in the nucm∆ and nukm∆ mutants ( Figure 4C ). In the nubm∆ mutant a nearly full-size complex I was detected by immunolabelling which has no NADH:NBT activity, consistent with NUBM being the site of NADH oxidation. In the ind1∆ mutant, an assembly intermediate containing both NUBM and NUCM was seen at approximately 500 kDa which was also found in cWT ( Figure 4C 
ind1 mutants are sensitive to cold
During storage of Y. lipolytica strains, it was noticed that the ind1∆ mutant was sensitive to cold, exacerbating the mild growth defect. To investigate this further, the growth of ind1 mutants, as well as nucm∆ + NUCM Y144F , nubm∆ and nukm∆, was compared at 28°C and 10°C. Cells were spotted onto agar plates in a dilution series and, after incubation of the plates overnight at 28°C plates to initiate growth, were placed either at 28°C for a further two days or moved to 10°C for 10-14 days. At 28°C all strains grew similarly, despite slight variations in colony size ( Figure 6 , left panels). However, when grown at 10°C some strains displayed a dramatic growth retardation ( Figure 6 , right panels). The ind1∆ strain expressing wild-type IND1, Ind1 variant G136D, nubm∆ and nukm∆ all displayed significant growth at 10°C. However, all other strains at 10°C displayed very slow, or no further growth. Interestingly, the nubm∆ and nukm∆ mutants were able to grow in cold conditions but nucm∆ + NUCM Y144F could not grow, similar to the ind1∆ mutant.
These data reveal a novel growth difference of certain complex I mutants grown at normal (28°C) or cold (10°C) conditions. Ind1 variants, except for G136D, also display this temperature-dependent growth defect.
Complex I assembly in the Ind1 G285C variant is temperature-sensitive
The Ind1 variant G285C has normal levels and activity of complex I ( Figure 3A ). However, it accumulated the Q-module intermediate ( Figure 5B ) and growth at 10°C was impaired ( Figure   6 ). To investigate if assembly of complex I in the G285C variant is conditional on temperature, mitochondrial membranes were isolated cells producing wild type Ind1 (cWT) and the Ind1 G285C variant after overnight growth at 10°C and compared to samples grown at 28°C. Mitochondrial membranes were separated by BN-PAGE and stained with NADH:NBT to assess formation of complex I. cWT displayed full complex I formation in cultures grown at both 28°C and 10°C ( Figure 7A ). By contrast, the G285C Ind1 variant could not support complex I assembly when grown at 10°C, with complex I levels decreased to those in the ind1∆ mutant ( Figure 4C ). BN-PAGE followed by Western blotting and labelling with antibodies against NUBM confirmed the significant decrease in complex I ( Figure 7A ). Immunodetection of Ind1 showed that the G285C protein variant is stable at 10°C, meaning the decrease in complex I levels is not due to a cold-dependent degradation of the Ind1 G285C protein.
Next, the effect of cold conditions on assembly intermediates of complex I was assessed. BN-PAGE followed by Western blotting with antibodies against NUCM displayed different patterns between mitochondria isolated at normal and cold temperatures ( Figure 7B ). Ind1 G285C samples from cold conditions lacked a band corresponding to the assembly intermediate at 500 kDa, made up of the N and Q modules, and an increase in the Q module intermediate at 160 kDa. This suggests that the Ind1 G285C variant accumulates greater levels of the Q module at cold temperatures as it is unable to assemble it into the 500 kDa intermediate. There is still a strong signal at the size corresponding to complex I, however this is due to a long exposure time needed to see assembly intermediates. Taken together these data show that the Ind1 G285C variant is more severely impaired in complex I assembly when grown in cold conditions.
Discussion
Since NUBPL was associated with mitochondrial disease resulting from complex I deficiency (1, 11) , the gene is routinely included in the list of candidate genes when making a genetic diagnosis. In children's hospitals around the world, additional mutations have been found in NUBPL that are likely to be pathogenic. In this study 5 protein variants of human NUBPL were recreated in the homologous Ind1 protein in the yeast Y. lipolytica to study the effect of the amino acid changes on complex I assembly and to confirm pathogenicity. (Figure 7) . Glycine 285 is located at the end of two short alpha helices ( Figure 1C ), and a cysteine may disrupt this structure. Alternatively, the cysteine, if exposed, may form an unwanted disulfide bridge with another cysteine, in particular the cysteines of the CxxC motif, which are important for the function of NUBPL/Ind1 (8, 10) . A Gly to Cys substitution in Nfu1, a mitochondrial protein involved in FeS cluster assembly that also carries a CxxC motif, causes a dominant genetic effect in yeast (31) and severe mitochondrial disease in humans (32) . Why the effects of G285C are exacerbated at cold temperatures remains an open question.
The cold-sensitive phenotype has not been reported in other mitochondrial mutants, to our knowledge. At the normal growth temperature of 28°C, Y. lipolytica containing Ind1 variants and complex I mutants grew similarly to cWT, because NADH oxidation in these strains is maintained by expression of ND2i, a single subunit NADH dehydrogenase on the matrix side.
However, at 10°C, functionally compromised Ind1 variants and nucm∆ + NUCM Y144F displayed almost no growth, whereas the nubm∆ and nukm∆ strains were comparable to cWT in cold tolerance ( Figure 6 ). The reason for these different growth phenotypes remains unclear. An initial hypothesis is that strains with a non-functional complex I produce large amounts of reactive oxygen species (ROS) such as superoxide (5), which may be exacerbated in the cold.
The nukm∆ mutant lacks complex I completely, and the nubm∆ lacks the FMN site where most ROS is produced. Further investigation is needed to uncover the cause of this growth defect.
In summary four of the six mutations (L104P, D105Y, L193F and G285C) were classed as pathogenic and one (G138D) was classed as potentially pathogenic. Along with other studies (17, 20, 33, 34) these results reconfirm the utility of Y. lipolytica as a model for human mitochondrial disorders. However, care must be taken in over-interpreting the results as some effects seen in Y. lipolytica have not been found in humans. In human NUBPL RNAi HeLa lines, the levels of NDUFV1 subunit are substantially decreased (10) , whereas in the Y. lipolytica ind1∆ mutant, the levels of the homologous NUBM protein are only slightly less than in cWT. Secondly, the Ind1 D103Y variant appears to have stable protein levels in Y. lipolytica, but human patients with D105Y have almost no NUBPL protein (11) . Ideally all NUBPL mutations should also be tested in human cell lines, although Y. lipolytica is useful as a costeffective model to study potentially pathogenic mutations affecting complex I.
A defect in Q-module assembly in Y. lipolytica ind1 mutants is consistent with studies of NUBPL in human cell lines (10, 11) . The Q-module has 3 FeS clusters that may be specifically inserted by NUBPL. However, detailed proteomic analysis of complex I assembly intermediates did not find NUBPL associated with any subcomplexes, it only occurred as a dimer (35) . Possibly, NUBPL interacts with an individual Q-module subunit or the protein interaction with the Q-module assembly intermediate is transient. The Ind1 protein variants characterized in this study, in particularly the D103Y variants, could serve as a tool to unravel exactly which step in complex I assembly is mediated by NUBPL/Ind1.
Materials and Methods
GenBank Accession Numbers
NUBPL, Homo sapiens: NG_028349.1; NP_079428.2 Ind1, Yarrowia lipolytica: XP_501064.1
Yeast strains and growth
The Y. lipolytica ind1∆ strain in the GB10 genetic background (ura3-302, ind1::URA3, leu2-270, lys11-23, NUGM-Htg2, NDH2i, MatB) was used to analyse mutant versions of IND1 and has been described previously (8) . The IND1 gene (YALI0B18590g) including its native promoter (1 kb upstream of the ATG) was reintroduced using the pUB4 plasmid (22) (Table S2 ). Mutated IND1-strep sequence was inserted into pUB4, between XbaI and NsiI restriction sites. Plasmids were confirmed by sequencing and diagnostic restriction digest.
Y. lipolytica cells were transformed as described (37) . Briefly, cells were grown overnight in 
Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
Unsealed mitochondrial membranes were isolated as published (16) with minor modifications.
Briefly, Y. lipolytica cells from 0.5 l overnight culture were harvested by centrifugation at 3,500
x g. Pellet weights were typically between 2-8 g. Cells were washed with dH 2 0. Per gram cells, Zickermann. Rabbit polyclonal antibodies against Sdh2 and Aco1 were raised against recombinant Saccharomyces cerevisiae proteins and previously reported (38) ; antibodies against Y. lipolytica Ind1 are described in (8) .
Protein was transferred from the BN-PAGE gel to a PVDF membrane (0.2 micron, Millipore™)
using wet transfer and BN cathode buffer, for 600 minutes at 40 mA, (maximum voltage 100 V). After transfer immunolabelling was carried out as described above.
NADH dehydrogenase assays
BN gels were stained for complex I, as described in (23) . Briefly, BN gels were equilibrated in NADH:HAR oxidoreductase activity was assayed as described (8) . NADH:HAR oxidoreductase activity was measured as NADH oxidation in the presence of the artificial electron acceptor hexaammineruthenium(III) chloride (HAR). A 1 ml, 10 mm quartz cuvette was used and. Activity for 25 µg mitochondria was measured in a 1-ml volume of 20 mM HEPES-NaOH pH 8.0, 2 mM NaN 3 , 0.2 mM NADH, 2 mM HAR and 40 µg ml -1 alamethicin.
Measurements made in a quartz cuvette using a UV/Vis spectrophotometer (Jasco, V-550)
and started after addition of HAR. Bars represent the mean ± SE (n = 3 biological replicates). * p<0.05, ** p<0.01 (two-sample ttest). Numerical values are given in Table S1 . 11) ) could not confirm whether the mutations were homozygous or hemizyogous because no parental DNA or fibroblasts were available for study. However, given the other cases, it is possible that another mutation in NUBPL is present to give a compound heterozygous situation. Western blots were labelled with antibodies against Ind1 and the complex I subunits NUBM and NUCM, as indicated. Antibodies against mitochondrial aconitase, Aco1, were used to confirm equal loading and protein transfer. The immunoblots were exposed for a relatively long time to visualize all assembly intermediates, which also revealed residual complex I lacking NUBM in the nubm∆ mutant. 
